文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

链脲佐菌素诱导的β细胞损伤及胰腺胰高血糖素样肽-1 基因治疗期间小鼠胰岛的全基因表达谱分析。

Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy.

机构信息

Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Dis Model Mech. 2013 Sep;6(5):1236-45. doi: 10.1242/dmm.012591. Epub 2013 Jul 4.

DOI:10.1242/dmm.012591
PMID:23828045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3759343/
Abstract

Streptozotocin (STZ), a glucosamine-nitrosourea compound, has potent genotoxic effects on pancreatic β-cells and is frequently used to induce diabetes in experimental animals. Glucagon-like peptide-1 (GLP-1) has β-cell protective effects and is known to preserve β-cells from STZ treatment. In this study, we analyzed the mechanisms of STZ-induced diabetes and GLP-1-mediated β-cell protection in STZ-treated mice. At 1 week after multiple low-dose STZ administrations, pancreatic β-cells showed impaired insulin expression, while maintaining expression of nuclear Nkx6.1. This was accompanied by significant upregulation of p53-responsive genes in islets, including a mediator of cell cycle arrest, p21 (also known as Waf1 and Cip1). STZ treatment also suppressed expression of a wide range of genes linked with key β-cell functions or diabetes development, such as G6pc2, Slc2a2 (Glut2), Slc30a8, Neurod1, Ucn3, Gad1, Isl1, Foxa2, Vdr, Pdx1, Fkbp1b and Abcc8, suggesting global β-cell defects in STZ-treated islets. The Tmem229B, Prss53 and Ttc28 genes were highly expressed in untreated islets and strongly suppressed by STZ, suggesting their potential roles in β-cell function. When a pancreas-targeted adeno-associated virus (AAV) vector was employed for long-term Glp-1 gene delivery, pancreatic GLP-1 expression protected mice from STZ-induced diabetes through preservation of the β-cell mass. Despite its potent β-cell protective effects, however, pancreatic GLP-1 overexpression showed limited effects on the global gene expression profiles in the islets. Network analysis identified the programmed-cell-death-associated pathways as the most relevant network in Glp-1 gene therapy. Upon pancreatic GLP-1 expression, upregulation of Cxcl13 and Nptx2 was observed in STZ-damaged islets, but not in untreated normal islets. Given the pro-β-cell-survival effects of Cxcl12 (Sdf-1) in inducing GLP-1 production in α-cells, pancreatic GLP-1-mediated Cxcl13 induction might also play a crucial role in maintaining the integrity of β-cells in damaged islets.

摘要

链脲佐菌素（STZ）是一种氨基葡萄糖-亚硝脲化合物，对胰腺β细胞具有很强的遗传毒性作用，常用于诱导实验动物糖尿病。胰高血糖素样肽-1（GLP-1）具有β细胞保护作用，已知可防止β细胞受到 STZ 处理的影响。在这项研究中，我们分析了 STZ 诱导的糖尿病的机制和 GLP-1 介导的 STZ 处理的β细胞保护作用。在多次低剂量 STZ 给药后 1 周，胰腺β细胞表现出胰岛素表达受损，同时维持核 Nkx6.1 的表达。这伴随着胰岛中 p53 反应基因的显著上调，包括细胞周期停滞的介体 p21（也称为 Waf1 和 Cip1）。STZ 处理还抑制了与关键β细胞功能或糖尿病发展相关的广泛基因的表达，例如 G6pc2、Slc2a2（Glut2）、Slc30a8、Neurod1、Ucn3、Gad1、Isl1、Foxa2、Vdr、Pdx1、Fkbp1b 和 Abcc8，表明 STZ 处理的胰岛中存在整体β细胞缺陷。Tmem229B、Prss53 和 Ttc28 基因在未处理的胰岛中高表达，并被 STZ 强烈抑制，提示它们在β细胞功能中的潜在作用。当使用胰腺靶向腺相关病毒（AAV）载体进行长期 GLP-1 基因传递时，胰腺 GLP-1 表达通过保护β细胞质量使小鼠免受 STZ 诱导的糖尿病。然而，尽管其具有很强的β细胞保护作用，但胰腺 GLP-1 过表达对胰岛中的整体基因表达谱的影响有限。网络分析确定程序化细胞死亡相关途径是 GLP-1 基因治疗中最相关的网络。在胰腺 GLP-1 表达后，在 STZ 损伤的胰岛中观察到 Cxcl13 和 Nptx2 的上调，但在未处理的正常胰岛中没有观察到。鉴于 Cxcl12（Sdf-1）在诱导α细胞中 GLP-1 产生方面对β细胞生存的促进作用，胰腺 GLP-1 介导的 Cxcl13 诱导也可能在维持受损胰岛中β细胞的完整性方面发挥关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/5050c15699bc/DMM012591F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/53f597605e58/DMM012591F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/dafcf0ebcbbd/DMM012591F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/63051b4a4ee1/DMM012591F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/abba4294676d/DMM012591F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/8a259a403983/DMM012591F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/5050c15699bc/DMM012591F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/53f597605e58/DMM012591F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/dafcf0ebcbbd/DMM012591F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/63051b4a4ee1/DMM012591F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/abba4294676d/DMM012591F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/8a259a403983/DMM012591F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/298e/3759343/5050c15699bc/DMM012591F6.jpg

相似文献

[1]
Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy.

Dis Model Mech. 2013-7-4

[2]
DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.

Gene Ther. 2009-10-29

[3]
In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes.

Diabetes. 2010-9-14

[4]
Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1.

Mol Ther. 2007-1

[5]
Characterizing pancreatic β-cell heterogeneity in the streptozotocin model by single-cell transcriptomic analysis.

Mol Metab. 2020-7

[6]
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.

J Biol Chem. 2016-3-25

[7]
A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.

Diabetes Res Clin Pract. 2010-11-18

[8]
The role of preproglucagon peptides in regulating β-cell morphology and responses to streptozotocin-induced diabetes.

Am J Physiol Endocrinol Metab. 2023-3-1

[9]
The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.

Int J Biochem Cell Biol. 2013-5-13

[10]
A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice.

J Virol. 2011-9-21

引用本文的文献

[1]
Nrf2-and p53-inducible REDD2/DDiT4L/Rtp801L confers pancreatic β-cell dysfunction, leading to glucose intolerance in high-fat diet-fed mice.

J Biol Chem. 2025-5-21

[2]
Advanced therapy to cure diabetes: mission impossible is now possible?

Front Cell Dev Biol. 2024-11-19

[3]
Identification of novel genetic loci related to dromedary camel (Camelus dromedarius) morphometrics, biomechanics, and behavior by genome-wide association studies.

BMC Vet Res. 2024-9-18

[4]
Delineating mouse β-cell identity during lifetime and in diabetes with a single cell atlas.

Nat Metab. 2023-9

[5]
Type 2 Diabetes Mellitus and its comorbidity, Alzheimer's disease: Identifying critical microRNA using machine learning.

Front Endocrinol (Lausanne). 2022

[6]
Identification of protease serine S1 family member 53 as a mitochondrial protein in murine islet beta cells.

Islets. 2022-1-1

[7]
Trends of nanotechnology in type 2 diabetes mellitus treatment.

Asian J Pharm Sci. 2021-1

[8]
miR-363 Alleviates Detrusor Fibrosis via the TGF-β1/Smad Signaling Pathway by Targeting Col1a2 in Rat Models of STZ-Induced T2DM.

Mol Ther Nucleic Acids. 2020-7-10

[9]
Topologically selective islet vulnerability and self-sustained downregulation of markers for β-cell maturity in streptozotocin-induced diabetes.

Commun Biol. 2020-9-30

[10]
Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic α-cell transdifferentiation.

Biochem Pharmacol. 2020-12

本文引用的文献

[1]
Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.

Mol Ther. 2012-11-27

[2]
Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

Diabetes. 2012-1-20

[3]
Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models.

Lab Anim. 2011-4-8

[4]
Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats.

Circulation. 2011-3-14

[5]
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction.

Transplantation. 2011-3-27

[6]
In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes.

Diabetes. 2010-9-14

[7]
DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.

Gene Ther. 2009-10-29

[8]
Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.

J Biol Chem. 2008-3-28

[9]
Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt.

Diabetes. 2007-12

[10]
GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.

Cell Metab. 2006-11

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索